News
ADOC
10.29
0.00%
0.00
Edoc Acquisition announces termination of deal with Calidi Biotherapeutics
SPC Edoc Acquisition (NASDAQ:ADOC) <a href="https://seekingalpha....
Seekingalpha · 08/15 06:17
Edoc Acquisition Corp. Announces Termination of Merger Agreement with Calidi Biotherapeutics, Inc.
New York, NY, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”), a special purpose acquisition company, announced today the termination of its previously announced agreement and plan of merger (t...
GlobeNewswire · 08/12 21:56
BRIEF-Edoc Acquisition Corp - On August 11, 2022, Co Received Written Notice That Calidi Had Terminated The Merger Agreement
BRIEF-Edoc Acquisition Corp - On August 11, 2022, Co Received Written Notice That Calidi Had Terminated The Merger Agreement
Reuters · 08/12 21:46
Edoc Acquisition Corp. Reminds Shareholders to Vote and Announces Additional Contribution for Extension Amendment
NEW YORK, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”) encourages its shareholders to vote in favor of the proposal to amend its charter (the “Extension Amendment”) to extend the date by whi...
GlobeNewswire · 08/04 21:17
ADOCIA Announces Start of 3 Clinical Studies for BioChaperone® Combo with Partner Tonghua Dongbao
LYON, France, April 11, 2022--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes a...
Business Wire · 04/11 08:49
ADOCIA Strengthens Its Cash Position by 19 Million Euros Following a Real Estate Transaction
LYON, France, March 28, 2022--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic solutions for the treatment of diabetes and other ...
Business Wire · 03/28 16:00
Number of Shares and Voting Rights of Adocia as of February 28th, 2022
LYON, France, March 16, 2022--Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") charter ADOCIA SA, a F...
Business Wire · 03/16 17:00
Edoc Acquisition Corp. Reminds Shareholders to Vote in Favor of Extension Amendment
NEW YORK, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, and ADOCW) (“Edoc” or the “Company”) encourages its shareholders to vote in favor of the proposal to amend its charter (the “Extension Amendment”) to extend the date b...
GlobeNewswire · 02/07 14:06
Calidi Biotherapeutics in deal to go public through SPAC Edoc Acquisition
Calidi Biotherapeutics agreed to go public through a deal with Edoc Acquisition Corp. (NASDAQ:ADOC), which will value the company at about $450M. Calidi would be expected to have cash and
Seekingalpha · 02/02 18:45
BRIEF-Calidi Biotherapeutics And Edoc Acquisition Corp. Agree To Merge And Create A Publicly Listed, Clinical-Stage Biotechnology Company
reuters.com · 02/02 17:51
Calidi Biotherapeutics, Edoc Acquisition Agree To Merge; Transaction Anticipated To Close In Q2 2022
Calidi Biotherapeutics, Inc. ("Calidi" or the "Company"), a clinical-stage biotechnology company that is pioneering the development of cell-based delivery of oncolytic viruses, and Edoc
Benzinga · 02/02 17:42
BRIEF-Edoc Acquisition Confirms Funding To Extend Period To Consummate Initial Business Combination
reuters.com · 11/15/2021 22:03
BRIEF-EDOC Acquisition Corp Reports Sponsor Approval of Extension of Deadline to Complete Business Combination
reuters.com · 11/09/2021 22:38
Do Insiders Own Lots Of Shares In Edoc Acquisition Corp. (NASDAQ:ADOC)?
If you want to know who really controls Edoc Acquisition Corp. ( NASDAQ:ADOC ), then you'll have to look at the makeup...
Simply Wall St. · 08/19/2021 10:48
EDOC Acquisition Corp. Reports Regained Nasdaq Compliance Related To Delayed Annual Report
EDOC Acquisition Corp. (NASDAQ:ADOCU) (the “Company”) announced today that it has filed with the Securities and Exchange Commission (“SEC”) its Annual Report on Form 10-K for the period ended
Benzinga · 05/28/2021 21:01
BRIEF-Edoc Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Annual Report
reuters.com · 04/22/2021 22:16
Edoc Acquisition receives Nasdaq notice for delay in filing annual report
Edoc Acquisition (ADOC) receives a notice from NASDAQ for failure to file Form 10-K for the fiscal year ended December 31, 2020.The delay is likely due to initial public offerings of special purpose
Seekingalpha · 04/22/2021 22:00
Edoc Acquisition Reports Received Notice From Nasdaq Listing Department Related To Failure To File 10-K In Timely Fashion
Edoc Acquisition Corp. (NASDAQ:ADOC) (the “Company”) announced today that it received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market
Benzinga · 04/22/2021 21:28
More
Webull provides a variety of real-time ADOC stock news. You can receive the latest news about Edoc Acquisition through multiple platforms. This information may help you make smarter investment decisions.
About ADOC
Edoc Acquisition Corp. is a blank check company. The Company is created for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company focuses on businesses primarily operating in the health care and health care provider space in North America and Asia-Pacific. The Company has no operations and has no revenues.